Interpace Biosciences, Inc. (IDXG)
6.025
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Interpace Biosciences Cash from Investing (Quarterly) : -0.057M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.057M |
| March 31, 2026 | -0.141M |
| December 31, 2025 | -0.038M |
| September 30, 2025 | -0.117M |
| June 30, 2025 | -0.201M |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.129M |
| September 30, 2024 | -0.522M |
| June 30, 2024 | -0.197M |
| March 31, 2024 | -0.028M |
| December 31, 2023 | -0.142M |
| September 30, 2023 | 0.348M |
| June 30, 2023 | -0.228M |
| March 31, 2023 | -0.065M |
| December 31, 2022 | -1.099M |
| September 30, 2022 | 7.391M |
| June 30, 2022 | -0.067M |
| March 31, 2022 | -0.019M |
| December 31, 2021 | -0.162M |
| September 30, 2021 | -0.144M |
| June 30, 2021 | -0.048M |
| March 31, 2021 | 0.039M |
| December 31, 2020 | -0.30M |
| September 30, 2020 | -0.362M |
| June 30, 2020 | -0.913M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.026M |
| September 30, 2019 | -13.89M |
| June 30, 2019 | -0.036M |
| March 31, 2019 | 0.001M |
| December 31, 2018 | -0.061M |
| September 30, 2018 | -0.309M |
| June 30, 2018 | -0.019M |
| March 31, 2018 | -0.06M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.029M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | |
| September 30, 2015 | -0.041M |
| June 30, 2015 | -0.078M |
| March 31, 2015 | -0.464M |
| December 31, 2014 | -14.91M |
| September 30, 2014 | -8.938M |
| June 30, 2014 | -0.432M |
| March 31, 2014 | -1.083M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Medical Marijuana, Inc. | 0.0026M |
| Acro Biomedical Co. Ltd. | 0.00 |
| Stella Diagnostics, Inc. | 0.00 |
| ZeroStack Corp. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.098M |
| Free Cash Flow | 4.104M |
| Free Cash Flow Per Share (Quarterly) | 0.0074 |
| Free Cash Flow to Equity (Quarterly) | 0.147M |
| Free Cash Flow to Firm (Quarterly) | 0.041M |
| Free Cash Flow Yield | 12.29% |